CoreRx Adds Investment to Expand Oral Dosage Form Capabilities

Investment Will Enhance Development, Scale-up, and Tech Transfer…
CoreRx, Inc. names Deborah Wild as Executive Chairwoman of the Board

CoreRx, Inc. names Deborah Wild as Executive Chairwoman of the Board

CLEARWATER, FL, June 1, 2021, CoreRx, Inc., is pleased to announce…

CoreRx Acquires Nucleo Life Sciences

Acquisition Creates Unparalleled East / West Coast Development…

CoreRx Inc. receives approval for Schedule I controlled drug manufacture

Approval now extends ability to develop and manufacture all scheduled…

CORERX, INC. FULLY OPERATIONAL IN NEW PRODUCT DEVELOPMENT CENTER

CORERX, INC. FULLY OPERATIONAL IN NEW PRODUCT DEVELOPMENT CENTER Company…
graph lab

CoreRx, Inc. Announces Commercial Supply Agreement for Aimmune Therapeutics’ Investigational Peanut Allergy Treatment

Clearwater, Florida, May 14, 2019 — CoreRx, Inc. today announced that…